Smithers Experts to Lead Webinar Covering Elemental Impurities Testing for Pharmaceutical Packaging

AKRON, Ohio - June 8, 2018 - PRLog -- Smithers Rapra, a world leader in rubber, plastics, and composites analysis, has opened registration for the final installment of its three-part webinar series providing an overview on selected United States Pharmacopeia (USP) general chapters, featuring Dr. Daniel Norwood, Independent Senior Consultant, and Michael Creese, Manager, Chemical Analysis.

The final webinar, titled "Overview of Guidance & Standards for Elemental Impurities," will take place on Thursday, June 14, at 10 am EST. Dr. Norwood and Mr. Creese will deliver a 45-minute presentation addressing changes of note that have affected pharmaceutical packaging testing standards USP <232> and ICH Q3D. Specific considerations include:

• The development of new elemental impurities standards.
• Modern analytical techniques for elemental impurities.
• The differences between USP <232> and USP elemental extractables standards.

"Elemental impurities in drug products can originate from a variety of sources, making extractables and leachables assessments an important piece in ensuring the safety of medicines," said Nat Leonard, President, Smithers Rapra. "Our goal with these webinars is to support the pharmaceutical industry by connecting them to experts like Daniel and Michael who each have years of experience in these assessments and represent the global footprint of our analytical services expertise."

Dr. Norwood partnered with Smithers in 2017 as a Senior Independent Consultant. He has over 41 years of experience in chemistry and pharmaceutical research and is recognized throughout the industry as a pioneer of extractables and leachables science. In addition to extractables and leachables ( analysis, his areas of expertise include structural analysis of pharmaceutical impurities and degradation products. He has a Doctorate of Philosophy in Environmental Chemistry from the University of North Carolina at Chapel Hill.

Mr. Creese joined Smithers in 2009. He has worked in extractables and leachables assessments both with biopharmaceuticals and pharmaceuticals for over 11 years. He uses his expertise to solve the challenges of single use system suppliers and users, as well as final container closure systems. Mr. Creese has a Bachelor of Science in Chemistry and is a Member of the Royal society of Chemistry (MRSC).

Click here to register ( this upcoming webinar. For those who are unable to make the live version, Smithers will publish recordings available for download at You can also access the previous webinars from this series:

• Part 1: Best Practices for the Design & Conduct of Extractables and Leachables Studies based on USP <1663> and <1664> (
• Part 2: Overview of USP Guidance & Standards for Packaging Systems (

Smithers offers a unique set of services in support of the development of medical devices or pharmaceutical packaging, from materials selection and assessments ( to final product performance (, packaging integrity (, and regulatory submissions. Visit to learn more about Smithers' full range of medical and pharmaceutical testing services.

About Smithers Rapra:

Smithers Rapra has been a trusted partner of the rubber and plastics industries for over 90 years. Our business is built around delivering a complete portfolio of rubber and plastic testing services to support a wide range of industry sectors including tire, automotive, polymer products, oil and gas, medical device, pharmaceutical, transport, packaging, industrial, and consumer products. By integrating science, technology and business expertise, Smithers adds value throughout the life cycle of our clients' products. Please

About The Smithers Group:

Headquartered in Akron, Ohio, The Smithers Group includes Smithers Apex, Smithers Avanza, Smithers Pira, Smithers Quality Assessments, Smithers Rapra, and Smithers Viscient. Each Smithers Group company provides technology-based services focused on a defined market. As a group, the diversity of market sectors and technologies provides stability and a platform for long-term growth. By integrating science, technology and business expertise, Smithers' goal is to add value throughout the lifecycle of our clients' products, by utilizing testing, consulting, information, and compliance services. All Smithers companies are known by their clients as Trusted Providers of Innovative Solutions. For more information,

You can reach the Smithers Rapra North America office at:

425 West Market Street

Akron, Ohio 44303

Telephone: 330-762-7441

Smithers Rapra
Source: » Follow
Email:*** Email Verified
Tags:Pharmaceutical, Usp, Testing
Location:Akron - Ohio - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Smithers Rapra News
Most Viewed
Daily News

Like PRLog?
Click to Share